Timmerman Report: Matchpoint gets $100M to take covalent binders into autoimmune disease
Read More
Archive for Uncategorized
BioSpace: Sanofi-backed Matchpoint launches with $100M for precision covalent medicines
Read More
Boston Business Journal: Sanofi backs $100M round for startup targeting immune system diseases
Read More
BioCentury: Matchpoint: a toolkit to create covalent therapies for immunology
Read More
Matchpoint Therapeutics launches with $100 million to deliver on the promise of precision covalent medicines for immune diseases
Read More